N/A
- Specialty & Fine Chemicals
- D-Dimer Market
D-Dimer Market
D-Dimer Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025
Introduction
D-dimer comprises of two D fragments of the fibrin protein that get cross-linked after fibrinolysis of a blood clot, which is found in the human blood samples. The concentration of these D-dimers present in the patient blood samples help in the diagnosis of thrombosis.
This test becomes very useful for those patients who are susceptible towards thrombotic disorders like venous thromboembolism.On the basis of disease diagnoses, the D-dimer market can be classified into three major segments namely, pulmonary embolism, deep venous thrombosis and others.
Major driving factors for the growth of this market include, increasing prevalence of various cardiovascular and pulmonary diseases, rising incidence of heart strokes, pulmonary embolisms etc. and increasing demand for technologically advanced coagulation testing methods.
Increasing prevalence of various cardiovascular and pulmonary diseases can cause life threatening problems, when accompanied by blood clots in the arterial or pulmonary pathway. Thus, the demand for D-dimer tests will augment, and hence will contribute towards the growth of the overall market.
Technological advancement in these D-dimer tests will bring more revenues to this market in the coming future. Specific and more sensitive markers are now being used to make these tests more accurate and reliable, which now encompasses automated instrumentation which will further make these tests more standardized.
Geographically, North America dominates the D-dimer market followed by Europe. Major factors responsible for the dominance of these regions in this market are demand for advanced diagnostics for these life threatening blood clots inside human organ systems.
Asia-Pacific region exhibited the fastest rate of growth due to increasing prevalence of cardiovascular diseases in the region combined with increasing affordability and awareness about these diagnostic tests. Some of the key players operating in this market are Abbott Laboratories, Inc., Beckman Coulter Inc.,Bio/Data Corporation,Becton, Dickinson and Company,Corgenix, F. Hoffmann-La Roche Ltd., NANOGEN, Siemens Healthcare, Thermo Fischer Scientific, Inc., and Trinity Biotech plc.
Geographies analyzed under this research report include
This research report analyzes this market depending on its market segments, major geographies, and current market trends.
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players.
The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
